Exagen Inc. (XGN) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin (GAAP) | 59.00 percent | FY2026-Q1 |
| Trailing Twelve-Month Average Selling Price for Advised Connective Tissue Disease Testing | 444.00 | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | -2.2M | FY2024-Q4 |
Back to XGN overview · XGN earnings · XGN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.